If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 95.00
Bid: 93.00
Ask: 97.00
Change: 0.50 (0.53%)
Spread: 4.00 (4.301%)
Open: 96.50
High: 96.50
Low: 95.00
Prev. Close: 94.50
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of three new acquisition companies

4 Dec 2020 08:11

RNS Number : 5820H
Marwyn Value Investors Limited
04 December 2020
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

4 DECEMBER 2020

 

Marwyn Value Investors Limited ("MVIL" or the "Company")

 Launch of three new acquisition companies

 

 

The Company announces the admission to the standard segment of the Official List and to trading on the London Stock Exchange's Main Market of three new UK listed acquisition companies, Marwyn Acquisition Company I Limited, Marwyn Acquisition Company II Limited, and Marwyn Acquisition Company III Limited (together, the "New Acquisition Companies").

 

The current economic environment in the UK, Europe and North America has created strong demand for investment and innovation to back and develop companies that have the potential to grow through the transformational change taking place across a range of sectors. In order to continue the implementation of its investment strategy, Marwyn has developed an efficient listed acquisition company model that will enable trusted and successful management partners to identify value enhancing opportunities before raising additional capital.

 

The New Acquisition Companies will be agile in their investment approach and currently plan to explore opportunities across the Media & Entertainment, Technology & Software, Consumer E-commerce, Healthcare & Diagnostics and B2B Services.

 

In particular, with the support of the Marwyn team, the New Acquisition Companies will each target businesses that are positioned to take advantage of the structural change arising from an unprecedented acceleration of digitalisation, affecting the way people live, work and consume, and the way businesses operate, engage and sell to customers.

 

The New Acquisition Companies have each been backed by investment from a number of senior executives of previous successful acquisition companies launched by Marwyn (the "Manager Investors"). The Company is able to benefit from the long-standing relationships developed by Marwyn and from the Manager Investors' expertise as partners, advisors and investors to help build businesses in the public markets.

 

Manager Investors in each of the New Acquisition Companies

(holding >3% on admission)

Investor

Current or previous portfolio company

% holding on admission

Avril Palmer-Baunack

BCA Marketplace

4.86%

Tim Lampert

BCA Marketplace

4.86%

Darren Throop

Entertainment One

4.86%

Simon Vivian

Breedon Aggregates

4.86%

Mark Silver

Inspicio

4.86%

 

The Manager1 believes that the structure of the New Acquisition Companies represents a significant improvement on conventional listed acquisition vehicles, allowing for greater speed and flexibility in financing and execution combined with lower operating and transaction costs.

 

Funds managed by Marwyn2 have invested £525,000 into each of the New Acquisition Companies, representing, in each case, 75% of the ordinary equity and warrants. Additionally, funds managed by the Manager have entered into Forward Purchase Agreements with each of the New Acquisition Companies to subscribe, on a discretionary basis, up to a further £20 million for securities, which may be drawn for working capital, to fund due diligence and/ or as part of future share issuances to finance platform acquisitions.

 

The total investment attributable to the Company's Ordinary shares will initially be an aggregate of £1,206,230, representing 1.37% of the Ordinary share net asset value ("NAV"), measured at 20 November 2020, being the latest available NAV published by the Company. None of the investment is attributable to the Realisation shares.

 

1 Marwyn Asset Management Limited.

2 Marwyn Value Investors II LP and MVI II Co-Invest LP.

 

 

 

Company enquiries:

Scott Danks / Louisa Bonney

Telephone: 07700 720303

 

Gillian Martin / Richard Bootle / Owen Matthews

Liberum Capital Limited

Telephone: 020 3100 2200

 

PR enquiries:

Alex Child-Villiers / Will Barker

Temple Bar Advisory Limited

Telephone: 07795 425580 / 07827 960151

 

Notes to editors:

Marwyn Value Investors Limited is a closed-ended investment company on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Marwyn's previous 11 comparable listed acquisition companies that have acquired platform businesses have gone on to make 83 subsequent transactions, delivering £4.4 billion in equity profits and an aggregate return to shareholders of 126 per cent. on invested capital as at 31 October 2020. 

 

 

For further information see www.marwynvalue.com

 

A copy of this announcement will be available on the Company's website at www.marwynvalue.com/company-information/rns. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements. Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, or other applicable laws, regulations or rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUSRWRRKUURRA
Date   Source Headline
2nd May 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd May 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd May 202410:00 amRNSNet Asset Value - Ordinary Shares
1st May 20247:00 amRNSInterim Dividend to Ordinary Shareholders
30th Apr 20242:56 pmRNSShare Dealings
30th Apr 20247:00 amRNSAnnual Financial Statements December 2023
22nd Apr 202411:00 amRNSNet Asset Values
15th Apr 202411:00 amRNSNet Asset Values
9th Apr 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
9th Apr 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
9th Apr 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Mar 20243:26 pmRNSShare Transfer
21st Mar 20243:53 pmRNSNotification of Major Interests in Shares
21st Mar 20243:51 pmRNSNotification of Major Interests in Shares
20th Mar 20241:42 pmRNSShare Transfer
18th Mar 202411:00 amRNSNet Asset Values
11th Mar 202411:00 amRNSNet Asset Values
7th Mar 20241:52 pmRNSNotification of Major Interests in Shares
4th Mar 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
28th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
28th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
23rd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
23rd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
23rd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
14th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
2nd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
26th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
26th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
26th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
25th Jan 20247:00 amRNSInterim Dividend to Ordinary Shareholders
15th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
29th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
29th Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
29th Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
22nd Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
22nd Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
22nd Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
18th Dec 20235:53 pmRNSShare Dealings
15th Dec 202311:42 amRNSNotification of Major Interests in Shares
14th Dec 20231:02 pmRNSResult of AGM
14th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.